| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.08. | Modular Medical, Inc.: Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference | 284 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / August 5, 2026 / Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| 04.08. | Modular Medical to initiate first phase of Pivot pump launch in October | 1 | MassDevice | ||
| 03.08. | Modular Medical, Inc.: Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026 | 281 | ACCESS Newswire | First Phase of Strategic Rollout Targets Markets with Leading Insulin Pump Prescribers and Strong New Pump Adoption. Inizio will Provide Commercialization Expertise to Accelerate Awareness and Adoption... ► Artikel lesen | |
| 23.07. | Modular Medical forms advisory council for Pivot insulin pump | 3 | Investing.com | ||
| 23.07. | Modular Medical, Inc.: Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman | 287 | ACCESS Newswire | - Council to Provide Strategic Clinical Guidance on Commercialization, Patient Identification, Workflow Integration, and Evidence Generation SAN DIEGO, CA / ACCESS Newswire / July 23, 2026 / Modular... ► Artikel lesen | |
| 17.07. | Modular Medical inks IMO Health collab for insulin pump EHR integration | 2 | MassDevice | ||
| 16.07. | Modular Medical partners with IMO Health on patient identification tool | 5 | Investing.com | ||
| 16.07. | Modular Medical und IMO Health entwickeln Algorithmus zur Identifizierung von Diabetespatienten | 2 | Investing.com Deutsch | ||
| MODULAR MEDICAL Aktie jetzt für 0€ handeln | |||||
| 16.07. | Modular Medical, Inc.: Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records | 332 | ACCESS Newswire | Pilot Combines Clinician Guided Phenotypes with IMO Health's Unique Terminology Identifiers to Help Clinicians Easily Identify Patients Most Likely to Benefit from Pivot Insulin Pump TherapyAdvancing... ► Artikel lesen | |
| 15.07. | Modular Medical, Inc.: Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump | 234 | ACCESS Newswire | Completed Independent Study Strongly Supports Favorable Payor Receptivity to Pivot's Differentiated Design and Simplified User Experience, and provides further validation of significant progress towards... ► Artikel lesen | |
| 14.07. | Modular Medical, Inc.: Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery | 371 | ACCESS Newswire | 97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved OutcomesConducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless... ► Artikel lesen | |
| 01.07. | Modular Medical reicht Software-Verbesserungen für Pivot-System bei FDA ein | 2 | Investing.com Deutsch | ||
| 01.07. | Modular Medical, Inc.: Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements | 307 | ACCESS Newswire | Submission Covers Software Enhancements for Patient Flexibility and Customization of Pivot SAN DIEGO, CA / ACCESS Newswire / July 1, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company")... ► Artikel lesen | |
| 30.06. | Modular Medical startet kommerzielle Einführung seiner Insulinpumpe | 5 | Investing.com Deutsch | ||
| 30.06. | Modular Medical begins commercial insulin pump deployment | 2 | Investing.com | ||
| 30.06. | Modular Medical, Inc.: Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump | 402 | ACCESS Newswire | First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial CompanyPivot is the First Insulin Pump Designed to Address the Large, Underserved Population of Insulin-Dependent... ► Artikel lesen | |
| 30.06. | EXCLUSIVE: Modular Medical Advances Commercial Rollout With First Active Users Of Pivot Insulin Pump | 2 | Benzinga.com | ||
| 29.06. | Modular Medical, Inc. - 10-K, Annual Report | 5 | SEC Filings | ||
| 26.06. | Modular Medical begins shipping Pivot insulin pump to doctors | 1 | Investing.com | ||
| 26.06. | Modular Medical, Inc.: Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps | 307 | ACCESS Newswire | Pivot starter kits are now shipping to multiple endocrinology practices SAN DIEGO, CA / ACCESS Newswire / June 26, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,453 | +0,22 % | HEALWELL AI: HEALWELL Achieves Revenue of $33 Million, Improved Operating Cash Flow and a Strengthened Balance Sheet in Q2-2026 | HEALWELL achieved revenue from continuing operations of $33.0 million in Q2-2026 compared to revenue of $33.2 million in Q2-2025. Revenue remained consistent with the prior year, as one-time professional... ► Artikel lesen | |
| LIFEWARD | 7,850 | 0,00 % | Lifeward Out With Q2 Numbers | ||
| IMUNON | 1,390 | 0,00 % | Imunon outlines OVATION 3 enrollment pace of 0.5 patients per site per month while planning early 2027 OVATION 2 data presentation | ||
| INSPIRE MEDICAL SYSTEMS | 50,50 | -0,98 % | Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan | Generated second quarter revenue of $200.6 millionSecond quarter diluted EPS of $0.01; adjusted diluted EPS of $0.14Second quarter operating cash flow of $23.2 millionAnnounced strategic growth plan... ► Artikel lesen | |
| INSPIREMD | 0,675 | +1,50 % | InspireMD Inc.: InspireMD to Announce Second Quarter 2026 Financial Results | ||
| GT BIOPHARMA | 0,304 | 0,00 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| INOGEN | 5,100 | +0,99 % | Inogen Inc - 10-Q, Quarterly Report | ||
| MYOMO | 1,304 | -0,15 % | Myomo expects $45M-$47M full-year revenue while targeting second-half cash burn below $2M | ||
| INTELLIGENT BIO SOLUTIONS | 2,560 | +0,79 % | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | ||
| INCANNEX HEALTHCARE | 3,180 | +0,32 % | Incannex receives final A$5.1m R&D tax incentive refund | ||
| LEXARIA BIOSCIENCE | 6,080 | -0,65 % | Lexaria Bioscience Corp. - 8-K, Current Report | ||
| GLUCOTRACK | 0,371 | -1,65 % | Glucotrack Secures $5.5 Million Financing Through Equity And Convertible Debt | ||
| LENSAR | 6,350 | +0,95 % | LENSAR, Inc.: LENSAR to Report Second Quarter 2026 Results on August 13th, 2026 | ||
| HEARTBEAM | 0,572 | 0,00 % | HeartBeam receives patent for multi-modal cardiac sensing device | ||
| MINIMED GROUP | 17,100 | -4,83 % | BofA raises MiniMed Group stock price target to $24 on exchange timing |